Animalcare Group plc is focused on growing its veterinary business

Animalcare is a leading supplier of generic veterinary medicines and animal identification products to companion animal veterinary markets.

Trading performance excluding exceptional costs, grew by 4.4% to £2.8m

The Group has made good progress during the financial year, achieving a 17.0% increase in underlying* operating profit.

The directors present their annual report on the affairs of the Group

The principal activity of the Group during the year was the sales and distribution of veterinary medicines, identification and other products for companion animals.

Animalcare is made up of three product groups

All three product areas have continued to show solid performance during the 2014 financial year. With The Licensed Veterinary Medicines group growing by 9.5%.


Operational Highlights

  • Strong revenue growth from our Licensed Veterinary Medicines group, up 9.5% to £7.9m (2013: £7.2m)
  • Companion Animal Identification group sales and marketing strategy started to deliver with revenue growth of 7.8% to £2.4m (2013: £2.2m)
  • Animal welfare products has seen top line decline, with margin improvement in line with management intention to streamline lower value products
  • Three new products launched in the year
  • Investment in infrastructure and senior management team to position ourselves for future growth
  • IT investment creating a more robust infrastructure to business and Identichip database
Read the Operational Highlights

Revenue £m

+6.3% at £12.9m

2012 10.9
2013 12.1
2014 12.9

show raw data

View Highlights

Underlying* operating profit £m

+4.4% at £2.8m

2012 2.3
2013 2.7
2014 2.8

show raw data

View Highlights

Underlying* basic EPS pence

+2.9% at 10.8p

2012 9.3
2013 10.5
2014 10.8

show raw data

View Highlights

Chairman's Statement

I am pleased to announce that all three product areas have continued to show solid performance during the 2014 financial year. The Licensed Veterinary Medicines group, which is the main focus of our investment, has grown strongly in the current year by 9.5%. Animalcare is made up of three product groups: Licensed Veterinary Medicines, Companion Animal Identification and Animal Welfare products that are sold mainly through veterinary practices

Read the Chairman's Statement

Chief Executive's Review

Animalcare has again delivered record sales, up 6.3% to £12.9m, continuing its track record of top line growth.This result has been achieved against a backdrop of a veterinary market that is very slowly responding to the strengthening economy. Activities in the period can be split into the following three main areas: revenue delivery, product development pipeline and business infrastructure. I am very pleased with the progress we have made in all these areas. 

Read the Chief Executive's Review

Revenue Profile

Animalcare is a sustainable growing business in a growing market. In the year ended 30th June 2014 Animalcare recorded revenue and gross profit growth of 6.3% and 5.2% respectively; continuing its track record of top line growth.

Read the Investment Case & Strategy

Percentage of total Company Revenue

item value
Licensed Veterinary Medicines 7.9
Companion Animal Identification 2.4
Animal Welfare Products 2.6

show raw data